Generic placeholder image

Current Molecular Medicine

Author(s): Natália Tribuiani, Jocimar de Souza, Marcos Antônio de Queiroz Junior, Denicezar Angelo Baldo, Valéria de Campos Orsi and Yoko Oshima-Franco*

DOI: 10.2174/1566524021666210521125553

DownloadDownload PDF Flyer Cite As
In Situ Effects of Doxycycline on Neuromuscular Junction in Mice

Page: [349 - 353] Pages: 5

  • * (Excluding Mailing and Handling)

Abstract

Background: The antibacterial mechanism of doxycycline is known, but its effects on the nerve-muscle system are still not unclear.

Objective: The aim of the study was to combine molecular targets of the neuromuscular machinery using the in situ neuronal blocker effect of doxycycline, a semisynthetic second-generation tetracycline derivative, on mice neuromuscular preparations.

Methods: The effects of doxycycline were assessed on presynaptic, synaptic cleft, and postsynaptic neurotransmission, along with the muscle fiber, using the traditional myographic technique. Precisely, the effects of doxycycline were categorized into "all" or "nothing" effects depending on the concentration of doxycycline used; "all" was obtained with 4 μM doxycycline, and "nothing" was obtained with 1-3 μM doxycycline. The rationale of this study was to apply known pharmacological tools against the blocker effect of 4 μM doxycycline, such as F55-6 (Casearia sylvestris), CaCl2 (or Ca2+), atropine, neostigmine, polyethylene glycol (PEG 400), and d-Tubocurarine. The evaluation of cholinesterase enzyme activity and the diaphragm muscle histology were performed, and protocols on the neuromuscular preparation submitted to indirect or direct stimuli were complementary.

Results: Doxycycline does not affect cholinesterase activity nor causes damage to skeletal muscle diaphragm; it acts on ryanodine receptor, sarcolemmal membrane, and neuronal sodium channel with a postjunctional consequence due to the decreased availability of muscle nicotinic acetylcholine receptors.

Conclusion: In conclusion, in addition to the neuronal blocker effect of doxycycline, we showed that doxycycline acts on multiple targets. It is antagonized by F55-6, a neuronal Na+-channel agonist, and Ca2+, but not by neostigmine.

Keywords: Antibiotics, Doxycycline, Molecular targets, Neuromuscular junction, Tetracycline, Phrenic-nerve diaphragm preparation.

[1]
Chopra I, Hawkey PM, Hinton M. Tetracyclines, molecular and clinical aspects. J Antimicrob Chemother 1992; 29(3): 245-77.
[http://dx.doi.org/10.1093/jac/29.3.245] [PMID: 1592696]
[2]
Schnappinger D, Hillen W. Tetracyclines: antibiotic action, uptake, and resistance mechanisms. Arch Microbiol 1996; 165(6): 359-69.
[http://dx.doi.org/10.1007/s002030050339] [PMID: 8661929]
[3]
Bortolanza M, Nascimento GC, Socias SB, et al. Tetracycline repurposing in neurodegeneration: focus on Parkinson’s disease. J Neural Transm (Vienna) 2018; 125(10): 1403-15.
[http://dx.doi.org/10.1007/s00702-018-1913-1] [PMID: 30109452]
[4]
Orsucci D, Mancuso M, Filosto M, Siciliano G. Tetracyclines and neuromuscular disorders. Curr Neuropharmacol 2012; 10(2): 134-8.
[http://dx.doi.org/10.2174/157015912800604498] [PMID: 23204983]
[5]
National Research Council of the National Academies. Guide for the Care and Use of Laboratory Animals. 8th ed. Washington DC: National Academies Press 2012. Available from: https://grants.nih.gov/grants/olaw/Guide-for-the-Care-and-use-of-laboratory-animals.pdf
[6]
Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol 2010; 8(6)e1000412
[http://dx.doi.org/10.1371/journal.pbio.1000412] [PMID: 20613859]
[7]
Bülbring E. Observations on the isolated phrenic nerve diaphragm preparation of the rat. 1946. Br J Pharmacol 1997; 120(4)(Suppl.): 3-26.
[http://dx.doi.org/10.1111/j.1476-5381.1997.tb06771.x] [PMID: 9142393]
[8]
Thiermann H, Eyer P, Worek F. Muscle force and acetylcholinesterase activity in mouse hemidiaphragms exposed to paraoxon and treated by oximes in vitro. Toxicology 2010; 272(1-3): 46-51.
[http://dx.doi.org/10.1016/j.tox.2010.04.002] [PMID: 20385200]
[9]
Fontana Oliveira IC, Gutiérrez JM, Lewin MR, Oshima-Franco Y. Varespladib (LY315920) inhibits neuromuscular blockade induced by Oxyuranus scutellatus venom in a nerve-muscle preparation. Toxicon 2020; 187(187): 101-4.
[http://dx.doi.org/10.1016/j.toxicon.2020.08.023] [PMID: 32889027]
[10]
Werner AC, Ferraz MC, Yoshida EH, et al. The facilitatory effect of Casearia sylvestris Sw. (guaçatonga) fractions on the contractile activity of mammalian and avian neuromuscular apparatus. Curr Pharm Biotechnol 2015; 16(5): 468-81.
[http://dx.doi.org/10.2174/1389201016666150303160625] [PMID: 25751174]
[11]
Yoshida EH, Tribuiani N, Foramiglio AL, et al. A Highly polar phytocomplex involving rutin is responsible for the neuromuscular facilitation caused by Casearia sylvestris (guaçatonga). Curr Pharm Biotechnol 2016; 17(15): 1360-8.
[http://dx.doi.org/10.2174/1389201017666161117145947] [PMID: 27855599]
[12]
Oshima M, Leite GB, Rostelato-Ferreira S, Da Cruz-Höfling MA, Rodrigues-Simioni L, Oshima-Franco Y. Insights of the effects of polyethylene glycol 400 on mammalian and avian nerve terminals. Muscle Nerve 2010; 41(4): 540-6.
[http://dx.doi.org/10.1002/mus.21531] [PMID: 19941343]
[13]
de Souza J, Deamatis BS, Ishii FM, et al. Plants from Brazil used against snake bites: oleanolic and ursolic acids as antiophidian against Bothrops jararacussu venomWild Plants - The Treasure of Natural Healers. Boca Raton: CRC Press 2020; pp. 138-67.
[http://dx.doi.org/10.1201/9781003020134-9]
[14]
de Jong RH. Neural blockade by local anesthetics. Life Sci 1977; 20(6): 915-9.
[http://dx.doi.org/10.1016/0024-3205(77)90275-2] [PMID: 15173]
[15]
Vizi ES, Chaudhry IA, Goldiner PL, Ohta Y, Nagashima H, Foldes FF. The pre- and postjunctional components of the neuromuscular effect of antibiotics. J Anesth 1991; 5(1): 1-9.
[http://dx.doi.org/10.1007/s0054010050001] [PMID: 15278661]
[16]
Kang JM. Antibiotics and muscle relaxation. Korean J Anesthesiol 2013; 64(2): 103-4.
[http://dx.doi.org/10.4097/kjae.2013.64.2.103] [PMID: 23460933]
[17]
Wright CI, Geula C, Mesulam MM. Neurological cholinesterases in the normal brain and in Alzheimer’s disease: relationship to plaques, tangles, and patterns of selective vulnerability. Ann Neurol 1993; 34(3): 373-84.
[http://dx.doi.org/10.1002/ana.410340312] [PMID: 8363355]
[18]
Loeb MB, Molloy DW, Smieja M, et al. A randomized, controlled trial of doxycycline and rifampin for patients with Alzheimer’s disease. J Am Geriatr Soc 2004; 52(3): 381-7.
[http://dx.doi.org/10.1111/j.1532-5415.2004.52109.x] [PMID: 14962152]
[19]
Darvesh S, Reid GA, Martin E. Biochemical and histochemical comparison of cholinesterases in normal and Alzheimer brain tissues. Curr Alzheimer Res 2010; 7(5): 386-400.
[http://dx.doi.org/10.2174/156720510791383868] [PMID: 19939227]
[20]
Narita K, Akita T, Hachisuka J, Huang S, Ochi K, Kuba K. Functional coupling of Ca(2+) channels to ryanodine receptors at presynaptic terminals. Amplification of exocytosis and plasticity. J Gen Physiol 2000; 115(4): 519-32.
[http://dx.doi.org/10.1085/jgp.115.4.519] [PMID: 10736317]
[21]
Liu Q, Chen B, Yankova M, et al. Presynaptic ryanodine receptors are required for normal quantal size at the Caenorhabditis elegans neuromuscular junction. J Neurosci 2005; 25(29): 6745-54.
[http://dx.doi.org/10.1523/JNEUROSCI.1730-05.2005] [PMID: 16033884]
[22]
Laver DR, Baynes TM, Dulhunty AF. Magnesium inhibition of ryanodine-receptor calcium channels: evidence for two independent mechanisms. J Membr Biol 1997; 156(3): 213-29.
[http://dx.doi.org/10.1007/s002329900202] [PMID: 9096063]
[23]
Farrar MA, Johnston HM, Grattan-Smith P, Turner A, Kiernan MC. Spinal muscular atrophy: molecular mechanisms. Curr Mol Med 2009; 9(7): 851-62.
[http://dx.doi.org/10.2174/156652409789105516] [PMID: 19860664]
[24]
Nagashima M, Sasakawa T, Schaller SJ, Martyn JAJ. Block of postjunctional muscle-type acetylcholine receptors in vivo causes train-of-four fade in mice. Br J Anaesth 2015; 115(1): 122-7.
[http://dx.doi.org/10.1093/bja/aev037] [PMID: 25835024]